CDKN2A and neoplasm: Overexpression of p16 in tumor cells and stromal fibroblasts contributes to tumor progression by secreting proinflammatory cytokines (IL-1, IL-6 and IL-8) and proteases (e.g., matrix metalloproteinases) [77,78,79].